Emerging insights into the molecular biology of brain metastases

Biochemical Pharmacology

Volumn 83, Issue 3, 2012, Pages 305-314

  Chen, Guo ^a   Davies, Michael A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Angiogenesis; Animal models; Blood brain barrier; Brain metastasis; Microenvironment; Targeted therapy

Indexed keywords

BEVACIZUMAB; CETUXIMAB; DOXORUBICIN; FLUORESCEIN; GELATINASE A; HEPARANASE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEXOKINASE; INTEGRIN; JANUS KINASE; LAPATINIB; NEU DIFFERENTIATION FACTOR; PACLITAXEL; STAT PROTEIN; STAT3 PROTEIN; TRASTUZUMAB; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; WNT1 PROTEIN;

BLOOD BRAIN BARRIER; BRAIN METASTASIS; BREAST CANCER; CANCER CELL; CANCER PATIENT; CEREBROSPINAL FLUID; COLON CANCER; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; GLIA CELL; GLIOBLASTOMA; HUMAN; INTRACELLULAR SIGNALING; LUNG ADENOCARCINOMA; LUNG CANCER; MOLECULAR BIOLOGY; NONHUMAN; PERICYTE; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

EID: 84455161017     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.09.012     Document Type: Note

References (101)

1. B.D. Fox, V.J. Cheung, A.J. Patel, D. Suki, and G. Rao Epidemiology of metastatic brain tumors Neurosurg Clin N Am 22 2011 1 6 v
2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
3. A.F. Eichler, and J.S. Loeffler Multidisciplinary management of brain metastases Oncologist 12 2007 884 898 (Pubitemid 47328231)
4. K.E. Smedby, L. Brandt, M.L. Backlund, and P. Blomqvist Brain metastases admissions in Sweden between 1987 and 2006 Br J Cancer 101 2009 1919 1924
5. I.T. Gavrilovic, and J.B. Posner Brain metastases: epidemiology and pathophysiology J Neurooncol 75 2005 5 14 (Pubitemid 41548673)
6. D.R. Gandara, K. Chansky, K.S. Albain, B.R. Leigh, L.E. Gaspar, and P.N. Lara Jr. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504 J Clin Oncol 21 2003 2004 2010 (Pubitemid 46606390)
7. R. Arriagada, T. Le Chevalier, A. Riviere, P. Chomy, I. Monnet, and E. Bardet Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients Ann Oncol 13 2002 748 754 (Pubitemid 34567382)
8. M.H. Amer Chemotherapy and pattern of metastases in breast cancer patients J Surg Oncol 19 1982 101 105 (Pubitemid 12172051)
9. Y. Tsukada, A. Fouad, J.W. Pickren, and W.W. Lane Central nervous system metastasis from breast carcinoma. Autopsy study Cancer 52 1983 2349 2354 (Pubitemid 14205961)
10. M.A. Davies, P. Liu, S. McIntyre, K.B. Kim, N. Papadopoulos, and W.J. Hwu Prognostic factors for survival in melanoma patients with brain metastases Cancer 117 2011 1687 1696
11. S.M. de la Monte, G.W. Moore, and G.M. Hutchins Patterned distribution of metastases from malignant melanoma in humans Cancer Res 43 1983 3427 3433 (Pubitemid 13061609)
12. M.P. Mehta, P. Rodrigus, C.H. Terhaard, A. Rao, J. Suh, and W. Roa Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases J Clin Oncol 21 2003 2529 2536 (Pubitemid 46606335)
13. J.H. Sampson, J.H. Carter Jr., A.H. Friedman, and H.F. Seigler Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma J Neurosurg 88 1998 11 20 (Pubitemid 28018958)
14. L.J. Schouten, J. Rutten, H.A. Huveneers, and A. Twijnstra Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma Cancer 94 2002 2698 2705 (Pubitemid 34478086)
15. S.L. Morris, S.H. Low, R.P. A'Hern, T.G. Eisen, M.E. Gore, and C.M. Nutting A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma Br J Cancer 91 2004 829 833 (Pubitemid 39273770)
16. T. Fujimaki, D. Fan, A.H. Staroselsky, K. Gohji, C.D. Bucana, and I.J. Fidler Critical factors regulating site-specific brain metastasis of murine melanomas Int J Oncol 3 1993 789 799 (Pubitemid 23343485)
17. T. Fujimaki, J.E. Price, D. Fan, C.D. Bucana, K. Itoh, and T. Kirino Selective growth of human melanoma cells in the brain parenchyma of nude mice Melanoma Res 6 1996 363 371 (Pubitemid 26358444)
18. C. Zhang, F. Zhang, R. Tsan, and I.J. Fidler Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain Cancer Res 69 2009 828 835
19. L.L. Rubin, and J.M. Staddon The cell biology of the blood-brain barrier Annu Rev Neurosci 22 1999 11 28 (Pubitemid 29144879)
20. N.J. Abbott, L. Ronnback, and E. Hansson Astrocyte-endothelial interactions at the blood-brain barrier Nat Rev Neurosci 7 2006 41 53 (Pubitemid 41828930)
21. W.M. Pardridge Blood-brain barrier drug targeting: the future of brain drug development Mol Interv 3 2003 90 105 51
22. D. Zagzag, M. Goldenberg, and S. Brem Angiogenesis and blood-brain barrier breakdown modulate CT contrast enhancement: an experimental study in a rabbit brain-tumor model AJR Am J Roentgenol 153 1989 141 146 (Pubitemid 19171962)
23. R.D. Zhang, J.E. Price, T. Fujimaki, C.D. Bucana, and I.J. Fidler Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice Am J Pathol 141 1992 1115 1124
24. D.M. Long Capillary ultrastructure in human metastatic brain tumors J Neurosurg 51 1979 53 58 (Pubitemid 9213249)
25. C. Pozzilli, S. Bernardi, L. Mansi, P. Picozzi, F. Iannotti, and B. Alfano Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography J Neurol Neurosurg Psychiatry 51 1988 1058 1062
26. J.S. Lee, W.K. Murphy, B.S. Glisson, H.M. Dhingra, P.Y. Holoye, and W.K. Hong Primary chemotherapy of brain metastasis in small-cell lung cancer J Clin Oncol 7 1989 916 922 (Pubitemid 19172466)
27. H.J. Stemmler, M. Schmitt, A. Willems, H. Bernhard, N. Harbeck, and V. Heinemann Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier Anticancer Drugs 18 2007 23 28 (Pubitemid 44949792)
28. P.R. Lockman, R.K. Mittapalli, K.S. Taskar, V. Rudraraju, B. Gril, and K.A. Bohn Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer Clin Cancer Res 16 2010 5664 5678
29. K.E. Schlageter, P. Molnar, G.D. Lapin, and D.R. Groothuis Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties Microvasc Res 58 1999 312 328 (Pubitemid 29531878)
30. K. Yonemori, K. Tsuta, M. Ono, C. Shimizu, A. Hirakawa, and T. Hasegawa Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer Cancer 116 2010 302 308
31. N.J. Abbott, and I.A. Romero Transporting therapeutics across the blood-brain barrier Mol Med Today 2 1996 106 113 (Pubitemid 126407728)
32. R.A. Kroll, and E.A. Neuwelt Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means Neurosurgery 42 1998 1083 1099 discussion 99-100
33. J.F. Deeken, and W. Loscher The blood-brain barrier and cancer: transporters, treatment, and Trojan horses Clin Cancer Res 13 2007 1663 1674 (Pubitemid 46952931)
34. D.M. Lambert, F. Mergen, C.F. Berens, J.H. Poupaert, and P. Dumont Synthesis and pharmacological properties of 2-[S-acetylthiorphan]-1,3- diacylaminopropan-2-ol derivatives as chimeric lipid drug carriers containing an enkephalinase inhibitor Pharm Res 12 1995 187 191
35. M. Mazel, P. Clair, C. Rousselle, P. Vidal, J.M. Scherrmann, and D. Mathieu Doxorubicin-peptide conjugates overcome multidrug resistance Anticancer Drugs 12 2001 107 116 (Pubitemid 32207359)
36. K. Fabel, J. Dietrich, P. Hau, C. Wismeth, B. Winner, and S. Przywara Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin Cancer 92 2001 1936 1942 (Pubitemid 32952514)
37. P. Hau, K. Fabel, U. Baumgart, P. Rummele, O. Grauer, and A. Bock Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma Cancer 100 2004 1199 1207 (Pubitemid 38325948)
38. H. Brem, S. Piantadosi, P.C. Burger, M. Walker, R. Selker, and N.A. Vick Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group Lancet 345 1995 1008 1012
39. S. Fellner, B. Bauer, D.S. Miller, M. Schaffrik, M. Fankhanel, and T. Spruss Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo J Clin Invest 110 2002 1309 1318 (Pubitemid 35285757)
40. P. Breedveld, D. Pluim, G. Cipriani, P. Wielinga, O. van Tellingen, and A.H. Schinkel The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients Cancer Res 65 2005 2577 2582 (Pubitemid 40490054)
41. D. Fortin, C. Gendron, M. Boudrias, and M.P. Garant Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis Cancer 109 2007 751 760 (Pubitemid 46233237)
42. R.A. Kroll, M.A. Pagel, L.L. Muldoon, S. Roman-Goldstein, and E.A. Neuwelt Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor Neurosurgery 38 1996 746 752 discussion 52-4
43. S.A. Dahlborg, W.D. Henner, J.R. Crossen, C.M. Tableman, A. Petrillo, and R. Braziel Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy Cancer J Sci Am 2 1996 166 174
44. M.A. Davies, K. Stemke-Hale, E. Lin, C. Tellez, W. Deng, and Y.N. Gopal Integrated molecular and clinical analysis of AKT activation in metastatic melanoma Clin Cancer Res 15 2009 7538 7546
45. L. Ding, M.J. Ellis, S. Li, D.E. Larson, K. Chen, and J.W. Wallis Genome remodelling in a basal-like breast cancer metastasis and xenograft Nature 464 2010 999 1005
46. S.P. Shah, R.D. Morin, J. Khattra, L. Prentice, T. Pugh, and A. Burleigh Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution Nature 461 2009 809 813
47. I.J. Fidler, and M.L. Kripke Metastasis results from preexisting variant cells within a malignant tumor Science 197 1977 893 895 (Pubitemid 8168759)
48. O. Schmidt-Kittler, T. Ragg, A. Daskalakis, M. Granzow, A. Ahr, and T.J. Blankenstein From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression Proc Natl Acad Sci USA 100 2003 7737 7742 (Pubitemid 36760039)
49. Y. Husemann, J.B. Geigl, F. Schubert, P. Musiani, M. Meyer, and E. Burghart Systemic spread is an early step in breast cancer Cancer Cell 13 2008 58 68 (Pubitemid 350309740)
50. S.J. Kim, J.S. Kim, E.S. Park, J.S. Lee, Q. Lin, and R.R. Langley Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy Neoplasia 13 2011 286 298
51. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 2003 669 676 (Pubitemid 36749215)
52. D.W. Leung, G. Cachianes, W.J. Kuang, D.V. Goeddel, and N. Ferrara Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1989 1306 1309 (Pubitemid 20066716)
53. H.F. Dvorak, L.F. Brown, M. Detmar, and A.M. Dvorak Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am J Pathol 146 1995 1029 1039
54. D. Guo, Q. Jia, H.Y. Song, R.S. Warren, and D.B. Donner Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation J Biol Chem 270 1995 6729 6733
55. B.P. Eliceiri, R. Paul, P.L. Schwartzberg, J.D. Hood, J. Leng, and D.A. Cheresh Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability Mol Cell 4 1999 915 924 (Pubitemid 30054898)
56. L.S. Kim, S. Huang, W. Lu, D.C. Lev, and J.E. Price Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice Clin Exp Metastasis 21 2004 107 118 (Pubitemid 38988084)
57. S. Yano, H. Shinohara, R.S. Herbst, H. Kuniyasu, C.D. Bucana, and L.M. Ellis Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis Cancer Res 60 2000 4959 4967
58. K.P. Claffey, L.F. Brown, L.F. del Aguila, K. Tognazzi, K.T. Yeo, and E.J. Manseau Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis Cancer Res 56 1996 172 181 (Pubitemid 26010397)
59. B. Kusters, W.P. Leenders, P. Wesseling, D. Smits, K. Verrijp, and D.J. Ruiter Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis Cancer Res 62 2002 341 345 (Pubitemid 34106399)
60. J.J. Yin, L. Zhang, J. Munasinghe, R.I. Linnoila, and K. Kelly Cediranib/AZD2171 inhibits bone and brain metastasis in a preclinical model of advanced prostate cancer Cancer Res 70 2010 8662 8673
61. Y. Kienast, L. von Baumgarten, M. Fuhrmann, W.E. Klinkert, R. Goldbrunner, and J. Herms Real-time imaging reveals the single steps of brain metastasis formation Nat Med 16 2010 116 122
62. W.P. Leenders, B. Kusters, K. Verrijp, C. Maass, P. Wesseling, and A. Heerschap Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option Clin Cancer Res 10 2004 6222 6230 (Pubitemid 39287530)
63. H.S. Friedman, M.D. Prados, P.Y. Wen, T. Mikkelsen, D. Schiff, and L.E. Abrey Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma J Clin Oncol 27 2009 4733 4740
64. M.H. Cohen, Y.L. Shen, P. Keegan, and R. Pazdur FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme Oncologist 14 2009 1131 1138
65. N.E. Hynes, and H.A. Lane ERBB receptors and cancer: the complexity of targeted inhibitors Nat Rev Cancer 5 2005 341 354 (Pubitemid 40637826)
66. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 2001 127 137 (Pubitemid 33674041)
67. P.M. Guy, J.V. Platko, L.C. Cantley, R.A. Cerione, and K.L. Carraway 3rd Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity Proc Natl Acad Sci USA 91 1994 8132 8136
68. P.D. Bos, X.H. Zhang, C. Nadal, W. Shu, R.R. Gomis, and D.X. Nguyen Genes that mediate breast cancer metastasis to the brain Nature 459 2009 1005 1009
69. D. Palmieri, J.L. Bronder, J.M. Herring, T. Yoneda, R.J. Weil, and A.M. Stark Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain Cancer Res 67 2007 4190 4198 (Pubitemid 46815065)
70. L. Da Silva, P.T. Simpson, C.E. Smart, S. Cocciardi, N. Waddell, and A. Lane HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer Breast Cancer Res 12 2010 R46
71. M. Sun, C. Behrens, L. Feng, N. Ozburn, X. Tang, and G. Yin HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors Clin Cancer Res 15 2009 4829 4837
72. B. Gril, D. Palmieri, J.L. Bronder, J.M. Herring, E. Vega-Valle, and L. Feigenbaum Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain J Natl Cancer Inst 100 2008 1092 1103
73. N.U. Lin, V. Dieras, D. Paul, D. Lossignol, C. Christodoulou, and H.J. Stemmler Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer Clin Cancer Res 15 2009 1452 1459
74. M. Oliveira, S. Braga, J.L. Passos-Coelho, R. Fonseca, and J. Oliveira Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab Breast Cancer Res Treat 127 2011 841 844
75. A. Klaus, and W. Birchmeier Wnt signalling and its impact on development and cancer Nat Rev Cancer 8 2008 387 398 (Pubitemid 351589714)
76. V.M. Semenov, R. Habas, T.B. MacDonals, and X. He Snapshot: noncanonical Wnt signaling pathways Cell 131 2007 1378.e1
77. D.X. Nguyen, A.C. Chiang, X.H. Zhang, J.Y. Kim, M.G. Kris, and M. Ladanyi WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis Cell 138 2009 51 62
78. F. Klemm, A. Bleckmann, L. Siam, H.N. Chuang, E. Rietkotter, and D. Behme Beta-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis Carcinogenesis 32 2011 434 442
79. H. Yu, and R. Jove The STATs of cancer: new molecular targets come of age Nat Rev Cancer 4 2004 97 105 (Pubitemid 38198738)
80. T.X. Xie, F.J. Huang, K.D. Aldape, S.H. Kang, M. Liu, and J.E. Gershenwald Activation of stat3 in human melanoma promotes brain metastasis Cancer Res 66 2006 3188 3196
81. F.J. Huang, P.S. Steeg, J.E. Price, W.T. Chiu, P.C. Chou, and K. Xie Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis Cancer Res 68 2008 9634 9642
82. D. Palmieri, D. Fitzgerald, S.M. Shreeve, E. Hua, J.L. Bronder, and R.J. Weil Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis Mol Cancer Res 7 2009 1438 1445
83. E.I. Chen, J. Hewel, J.S. Krueger, C. Tiraby, M.R. Weber, and A. Kralli Adaptation of energy metabolism in breast cancer brain metastases Cancer Res 67 2007 1472 1486 (Pubitemid 46383371)
84. J.S. Desgrosellier, and D.A. Cheresh Integrins in cancer: biological implications and therapeutic opportunities Nat Rev Cancer 10 2010 9 22
85. T. Yoshimasu, T. Sakurai, S. Oura, I. Hirai, H. Tanino, and Y. Kokawa Increased expression of integrin alpha3beta1 in highly brain metastatic subclone of a human non-small cell lung cancer cell line Cancer Sci 95 2004 142 148 (Pubitemid 38404315)
86. M. Lorger, J.S. Krueger, M. O'Neal, K. Staflin, and B. Felding-Habermann Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain Proc Natl Acad Sci USA 106 2009 10666 10671
87. A. Harduin-Lepers, V. Vallejo-Ruiz, M.A. Krzewinski-Recchi, B. Samyn-Petit, S. Julien, and P. Delannoy The human sialyltransferase family Biochimie 83 2001 727 737 (Pubitemid 32821237)
88. I. Vlodavsky, Y. Friedmann, M. Elkin, H. Aingorn, R. Atzmon, and R. Ishai-Michaeli Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis Nat Med 5 1999 793 802 (Pubitemid 29318614)
89. D. Marchetti Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases J Cell Physiol 172 1997 334 342 (Pubitemid 27376199)
90. D. Marchetti, J. Li, and R. Shen Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase Cancer Res 60 2000 4767 4770
91. B.P. Murry, B.E. Blust, A. Singh, T.P. Foster, and D. Marchetti Heparanase mechanisms of melanoma metastasis to the brain: development and use of a brain slice model J Cell Biochem 97 2006 217 225 (Pubitemid 43167139)
92. L.D. Ridgway, M.D. Wetzel, and D. Marchetti Modulation of GEF-H1 induced signaling by heparanase in brain metastatic melanoma cells J Cell Biochem 111 2010 1299 1309
93. L. Zhang, P.S. Sullivan, J.C. Goodman, P.H. Gunaratne, and D. Marchetti MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase Cancer Res 71 2011 645 654
94. E. Benedettini, L.M. Sholl, M. Peyton, J. Reilly, C. Ware, and L. Davis Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis Am J Pathol 177 2010 415 423
95. Y. Shintani, S. Higashiyama, M. Ohta, H. Hirabayashi, S. Yamamoto, and T. Yoshimasu Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis Cancer Res 64 2004 4190 4196 (Pubitemid 38802422)
96. D.H. Nam, H.M. Jeon, S. Kim, M.H. Kim, Y.J. Lee, and M.S. Lee Activation of notch signaling in a xenograft model of brain metastasis Clin Cancer Res 14 2008 4059 4066
97. W. Cruz-Munoz, and R.S. Kerbel Preclinical approaches to study the biology and treatment of brain metastases Semin Cancer Biol 21 2011 123 130
98. W. Cruz-Munoz, S. Man, P. Xu, and R.S. Kerbel Development of a preclinical model of spontaneous human melanoma central nervous system metastasis Cancer Res 68 2008 4500 4505
99. D.P. Lawrence, O. Hamid, D.F. McDermott, I. Puzanov, M. Sznol, and J. Clark Phase II trail of ipilimumab monotherapy in melanoma patients with brain metastases J Clin Oncol 28 Suppl. 2010 abstr 8523
100. P.S. Steeg Heterogeneity of drug target expression among metastatic lesions: lessons from a breast cancer autopsy program Clin Cancer Res 14 2008 3643 3645
101. H. Zhao, K. Cui, F. Nie, L. Wang, M.B. Brandl, and G. Jin The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models Breast Cancer Res Treat 2011